ResearcherNankai UniversityNo recent work listed

Yin Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7102-323X; OpenAlex author ID A5100451129. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 2

The antitumor effect of the novel agent MCL/ACT001 in pancreatic ductal adenocarcinoma. First author DOI 10.1007/s00432-022-04542-9 ↗
Circadian Dysregulation of the TGFβ/SMAD4 Pathway Modulates Metastatic Properties and Cell Fate Decisions in Pancreatic Cancer Cells. Co-author DOI 10.1016/j.isci.2020.101551 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chenggang Li · 1 shared paper, 2023 · strength 0.22
- Paper The antitumor effect of the novel agent MCL/ACT001 in pancreatic ductal adenocarcinoma. DOI 10.1007/s00432-022-04542-9 ↗
Juan Yang · 1 shared paper, 2023 · strength 0.22
- Paper The antitumor effect of the novel agent MCL/ACT001 in pancreatic ductal adenocarcinoma. DOI 10.1007/s00432-022-04542-9 ↗
Angela Relógio · 1 shared paper, 2020 · strength 0.16
- Paper Circadian Dysregulation of the TGFβ/SMAD4 Pathway Modulates Metastatic Properties and Cell Fate Decisions in Pancreatic… DOI 10.1016/j.isci.2020.101551 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.